Skip to content

CAPSURE®SP NOVUS 5592-45 (UDI 00643169590724)Recalls & reported problems

Medtronic, Inc. · LEAD 5592-45 CAPSURE SP US BI SIL ATRL · Class 3 · Implant

All models of CapSureSP Novus (14)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169590724), received between Dec 9, 2016 and Apr 18, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Under-Sensing” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Under-Sensing2
  • Device Dislodged or Dislocated1
  • Failure to Capture1

Patient problems

  • Atrial Tachycardia1
  • Muscle Stimulation1
  • No Clinical Signs, Symptoms or Conditions1
  • Undesired Nerve Stimulation1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 18, 2025Under-Sensing; Under-Sensing

    IT WAS REPORTED THAT THE RIGHT ATRIAL (RA) LEAD EXHIBITED UNDERSENSING NOTED ON STORED ELECTROGRAMS (EGM). THE LEAD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21864497 ↗
  • MalfunctionFeb 8, 2018Under-Sensing; Under-Sensing

    IT WAS REPORTED THAT THE PATIENT EXPERIENCED ATRIAL TACHYCARDIA. UPON DEVICE INTERROGATION, IT WAS REVEALED THAT THERE WAS ATRIAL UN DER-SENSING AND MODE SWITCHING ON THE RIGHT ATRIAL (RA) LEAD. IT WAS ALSO NOTED THAT THERE WAS ONE UNDER-SENSED R-WAVE ON THE RIGHT VENTRICULAR (RV) LEAD. THE RA AND RV LEAD REMAIN IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Atrial Tachycardia

    MAUDE report 7254284 ↗
  • InjuryDec 9, 2016Failure to Capture; Device Dislodged or Dislocated; Failure to Capture; Device Dislodged or Dislocated

    IT WAS REPORTED THAT WITHIN ONE WEEK POST-IMPLANT, THE PATIENT WENT TO THE EMERGENCY ROOM DUE TO DIAPHRAGMATIC AND NERVE STIMULATION. DEVICE INTERROGATION REVEALED NO ATRIAL CAPTURE ALONG WITH INCREASED OUTPUT. X-RAY SHOWED THAT THE LEAD WAS PULLED BACK AND DISLODGED. THE ATRIAL LEAD WAS PROGRAMMED OFF UNTIL BEING REPOSITIONED THE NEXT DAY. THE LEAD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Muscle Stimulation; Undesired Nerve Stimulation

    MAUDE report 6157939 ↗

Other permanent pacemaker Electrode devices

All permanent pacemaker Electrode devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page